References
- Tekin R, Ari S, Dal T, et al. Evaluation of cutaneous palpebral anthrax. Cutan Ocul Toxicol 2013;32:294--298
- World Health Organization. Anthrax control and research, with special reference to national programme development in Africa: memorandum from a WHO meeting. BullWorld Health Organ 1994;72:13–22
- David S, Peter J, Raju R, et al. Oculocutaneous anthrax: detection and treatment. Clin Ophthalmol 2010;30:713–716
- Akbayram S, Doğan M, Akgün C, et al. Clinical findings in children with cutaneous anthrax in eastern Turkey. Pediatr Dermatol 2010;27:600–606
- Soysal HG, Kiratli H, Recep OF. Anthrax as the cause of preseptal cellulitis and cicatricial ectropion. Acta Ophthalmol Scand 2001;79:208–209
- Caça I, Cakmak SS, Unlü K, et al. Cutaneous anthrax on eyelids. Jpn J Ophthalmol 2004;48:268–271
- Weiner ZP, Glomski IJ. Updating perspectives on the initiation of Bacillus anthracis growth and dissemination through its host. Infect Immun 2012;80:1626–1633
- Ramsay CN, Stirling A, Smith J, et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Euro Surveill 2010;15:2--4
- Buzard GS, Baker D, Wolcott MJ, et al. Multi-platform comparison of ten commercial master mixes for probe-based real-time polymerase chain reaction detection of bioterrorism threat agents for surge preparedness. Forensic Sci Int 2012;30:292–297
- Amraoui A, Tabbara KF, Zaghloul K. Anthrax of the eyelids. Br J Ophthalmol 1992;76:753–754
- Lucey D. Bacillus anthracis (anthrax). In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practise of infectious diseases. New York: Churchill Livingstone; 2005:2215–2220
- Kayabas U, Karahocagil MK, Ozkurt Z, et al. Naturally occurring cutaneous anthrax: antibiotic treatment and outcome. Chemotherapy 2012;58:34--43